Updated: Share Article AAA Pharma manufacturing company Granules India has posted a consolidated net profit of ₹147 crore for the quarter ended December 31 compared with ₹64 crore in the year-earlier period. The firm has declared a third interim dividend of 25 paise per share (of face value of ₹1 each) for 2020-21. Income from operations at ₹845 crore (₹704 crore) was 20% higher on the back of four new launches and increase in marketshare of existing products across the API, PFI and FD business segments. CMD Krishna Prasad Chigurupati said “our long term investments in backward and forward integration from APIs to FDs is helping deliver expected results.”